Nuvectis Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVCT and other ETFs, options, and stocks.

About NVCT

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900.

CEO

Ronald E. Bentsur

CEORonald E. Bentsur

Employees

Employees13

Headquarters

Fort Lee, New Jersey

HeadquartersFort Lee, New Jersey

Founded

2020

Founded2020

Employees

Employees13

NVCT Key Statistics

Market cap

245.14M

Market cap245.14M

Price-Earnings ratio

-9.61

Price-Earnings ratio-9.61

Dividend yield

—

Dividend yield—

Average volume

188.21K

Average volume188.21K

High today

$11.08

High today$11.08

Low today

$9.40

Low today$9.40

Open price

$10.44

Open price$10.44

Volume

355.30K

Volume355.30K

52 Week high

$11.80

52 Week high$11.80

52 Week low

$4.44

52 Week low$4.44

People also own

Based on the portfolios of people who own NVCT. This list is generated using Robinhood data, and it’s not a recommendation.

SoundHound AI

Tonix Pharmaceuticals